
Alethea Capital Management, LLC is a Multi-Strategy Hedge Fund led by Tony Hsu, reporting $196.1M in AUM as of Q3 2025 with 74% Healthcare concentration, 94% concentrated in top 10 holdings, and 52% allocation to AXSM.
Largest long holdings in Alethea Capital Management, LLC's portfolio (94.5% of total portfolio)
| Holding | Sector | Position | Weight | Traded | Ownership |
|---|---|---|---|---|---|
Biotechnology Healthcare | $81.5M | 52.44% | +$426.9K Bought | 1.34% 670.9K shares | |
ETF ETF | $28.6M | 18.42% | +$39.7K Bought | — 312.0K shares | |
Biotechnology Healthcare | $19.4M | 12.51% | +$762.6K Bought | 0.31% 446.1K shares | |
Biotechnology Healthcare | $12.3M | 7.91% | +$3.9M Bought | 1.60% 1.4M shares | |
ETF ETF | $2.1M | 1.33% | — | — 23.1K shares | |
Drug Manufacturers - General Healthcare | $616.2K | 0.40% | +$616.2K Bought | 0.00% 3.3K shares | |
Biotechnology Healthcare | $570.4K | 0.37% | +$570.4K Bought | 0.02% 6.0K shares | |
REIT - Healthcare Facilities Real Estate | $562.7K | 0.36% | +$562.7K Bought | 0.00% 8.0K shares | |
Medical - Healthcare Plans Healthcare | $561.8K | 0.36% | +$561.8K Bought | 0.00% 1.6K shares | |
Packaged Foods Consumer Defensive | $561.5K | 0.36% | +$561.5K Bought | 0.00% 5.2K shares |
Portfolio activity, position movements, and quarter-over-quarter changes in Alethea Capital Management, LLC's latest filing
| Position | Shares Δ |
|---|---|
New | |
New | |
New | |
+46.3% | |
+4.08% |
| Position | Shares Δ |
|---|---|
Sold | |
Sold | |
Sold | |
Sold | |
Sold |
Portfolio insights and performance metrics for Alethea Capital Management, LLC
We use cookies for analytics. See our Privacy and Cookie Policy.